Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Medical Device Clinical Trials Market CAGR Outlook And Future Development
The medical device clinical trials market has experienced significant expansion in recent years. This market is projected to rise from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to several factors, including an increase in medical device innovation, strict regulatory approval mandates, a heightened demand for patient safety validation, the enlargement of hospital-based clinical research, and greater investment in generating clinical evidence.
The medical device clinical trials market size is projected to experience substantial expansion over the upcoming years. It is forecast to reach $25.35 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this anticipated growth during the forecast period include the rise of wearable and connected medical technologies, heightened regulatory oversight concerning device effectiveness, the proliferation of digital platforms for trials, a greater embrace of remote patient monitoring within studies, and the growing internationalization of clinical research. Key trends anticipated during the same period encompass the growing implementation of decentralized clinical trials, the expanding application of real-world evidence in device studies, an intensified emphasis on post-market approval and prolonged safety evaluations, the broadening of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
Medical Device Clinical Trials Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of chronic diseases is projected to drive the growth of the medical device clinical trials market moving forward. These are long-term health conditions that advance slowly and necessitate continuous medical management. The proliferation of chronic diseases stems from sedentary lifestyles, where individuals spend extended hours seated at desks or engaged with electronic devices. This behavior reduces calorie expenditure and weakens cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The escalating incidence of chronic diseases, in turn, boosts the requirement for medical device clinical trials to create and validate innovative devices for effective diagnosis, treatment, and management. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is accelerating the growth of the medical device clinical trials market.
Medical Device Clinical Trials Market Segment Landscape And Growth Outlook
The medical device clinical trials market covered in this report is segmented –
1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
3) By Study Design: Interventional, Observational, Expanded Access
Subsegments:
1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies
Medical Device Clinical Trials Market Trends Powering Strategic Industry Growth
Major companies active in the medical device clinical trials market are concentrating on developing AI-powered medical device software to streamline clinical trial protocols and resource allocation, aiming to boost trial efficiency and reduce expenditures. AI-powered medical device software refers to healthcare software that employs artificial intelligence algorithms, particularly machine learning or deep learning, to support or automate medical functions. For instance, in January 2025, Risklick, a pharmaceutical firm based in Switzerland, launched Protocol AI, an AI-driven software designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, thereby automatically drafting clinical trial protocols within minutes. This innovation significantly decreases the time and cost associated with protocol development, which traditionally takes approximately six months, and has already shown up to a 50% reduction in document development time for medicinal products.
Medical Device Clinical Trials Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
View The Full Medical Device Clinical Trials Market Report:
Medical Device Clinical Trials Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model